Big B says ‘work, medical restrictions kept him away’ from ‘Kalki 2898 AD’ panel at San Diego Comic-Con

Amitabh Bachchan

Amitabh Bachchan

BDC News

Mumbai, June 23  Megastar Amitabh Bachchan has finally revealed why he skipped the ‘Kalki 2898 AD’ panel at San Diego’s Comic-Con. He shared that filmmaker Nag Ashwin wanted him to come along but “work and medical restrictions have kept me away.”

Amitabh Bachchan

Amitabh took to his blog and wrote: “Alright… so… San Diego and K, the project… a great moment for the film and the makers and all those that went there for the release of the first look for it… I was pushed hard by Nagi Sir to come along but work and medical restrictions have kept me away from many such occasions.”

The Cine icon shared that the first look “was pretty darn good.”

“So… but I must admit that the first look was pretty darn good… wasn’t it… style, music, frames… everything… and finally the reveal of K… KALKI… mythologically so important… 2898 AD !!

‘AD’ has been changed has it not,” he wrote.

He then went on to explain the meaning of ‘AD’ in the film’s title.

“Yes .. AD, which I think was ‘anno domini’, meaning ‘in the year of the Lord’.. was changed to CE – common era .. and BC, became BCE – before common era! Why so… have no idea… it was related to the birth of Christ, before and after. hence .. but, each region in the World has its own year and month and named according to their calculated calendars.”

The San Diego Comic-Con was attended physically by Kamal Haasan, Prabhas, and Rana Daggubati. Big B joined the panel via a Zoom video call. In the event, it was announced that the film, which was earlier titled ‘Project K’, has been titled Kalki 2898 AD.

‘Kalki 2898 AD’ stars Amitabh Bachchan, Kamal Haasan, Prabhas, Deepika Padukone and Disha Patani also feature in the sci-fi film.

Produced by Vyjayanthi Movies, the film is scheduled to release on January 12, 2024.

 

--IANS
sms\rm
(This story has not been edited by BDC staff and is auto-generated from a syndicated feed from IANS.)
Writers are welcome to submit their articles for publication. Please contact us through Contact Us in the Menue
Exit mobile version